OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
Noriyuki Nishiwaki, Kazuhiro Noma, Toshiaki Ohara, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2029-2044
Open Access | Times Cited: 13

Showing 13 citing articles:

Interleukin-6 serves as a critical factor in various cancer progression and therapy
Asma’a H. Mohamed, Abdulrahman T. Ahmed, Waleed Al Abdulmonem, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 13

Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity
Masaaki Akai, Kazuhiro Noma, Takuya Kato, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 10, pp. 1647-1658
Open Access | Times Cited: 12

Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer
Ema Mitsui, Satoru Kikuchi, Tomohiro Okura, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
Yige Zhao, Yong Li, Panpan Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1

LAG‐3 : recent developments in combinational therapies in cancer
Aude Chavanton, Flavie Mialhe, Jimena Abrey, et al.
Cancer Science (2024) Vol. 115, Iss. 8, pp. 2494-2505
Open Access | Times Cited: 8

CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage
Rongyuan Wei, Junquan Song, Hongda Pan, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
Areez Shafqat, Mohamed H. Omer, Eman Nayaz Ahmed, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14

Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody
Teruki Kobayashi, Kazuhiro Noma, Seitaro Nishimura, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 7, pp. 1031-1042
Closed Access | Times Cited: 6

Targeting CAFs and extracellular matrix (ECM) in lung cancer: Potential of adjuvants and nanoparticles
Yuan Feng, Ying Jiang, Lin Yang, et al.
Bioorganic Chemistry (2025), pp. 108586-108586
Closed Access

Immunomodulatory Effect of Hypericin-Mediated Photodynamic Therapy on Oral Cancer Cells
Marcin Olek, Agnieszka Machorowska-Pieniążęk, Zenon Czuba, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 42-42
Open Access | Times Cited: 4

Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer Models
Satoshi Komoto, Kazuhiro Noma, Takuya Kato, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2971-2971
Open Access | Times Cited: 1

Single-cell RNA-Seq reveals the heterogeneity of fibroblasts within the tympanojugular paraganglioma microenvironment
Shengming Wang, Boya Zhang, Zihan Lou, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35478-e35478
Open Access

Page 1

Scroll to top